Skip to main content

EVA - patient ventilation beyond limits


Obtained CE marking

Obtaining CE marking

Obtained FDA approval

Obtaining FDA approval

Workshop organisation

After CE marking, per year >3 workshops in each country where we are represented by a distributor/Ventinova

Annual showcasing

Annual showcasing at ESA, ISICEM and EAMS

Evaluation of safe use in Pigs

Evaluation whether 6 hours EVA ventilation does not induce lung damage in pigs and as such is safe to use

Evaluation of lung protective effects

Evaluation whether EVA ventilation is lung protective in a setting of experimental lung damage, simulating the life threatening ARDS in humans

Reports of communication activities

Reports of communication activities form the partners

Submission for publication

Submission for publication of studies Task 2.1, 2.2, 2.3 and 2.5

Evaluation of benefit personalised care

Evaluation whether EVA ventilation has significant benefit in (I) patients undergoing upper airway surgery with oral intubation, (II) obese patients, (III) patients undergoing reconstruction surgery of tracheostomy and (IV) lung healthy patients with arterial line.


Improved lung recruitment and oxygenation during mandatory ventilation with a new expiratory ventilation assistance device

Author(s): Johannes Schmidt, Christin Wenzel, Marlene Mahn, Sashko Spassov, Heidi Cristina Schmitz, Silke Borgmann, Ziwei Lin, Jörg Haberstroh, Stephan Meckel, Sebastian Eiden, Steffen Wirth, Hartmut Buerkle, Stefan Schumann
Published in: European Journal of Anaesthesiology, Issue 35/10, 2018, Page(s) 736-744, ISSN 0265-0215
DOI: 10.1097/EJA.0000000000000819